Difficulties in diagnosis and variants of the clinical course of hypertrophic cardiomyopathy in elderly patients
- Authors: Krylova N.S.1,2, Maslova M.Y.1, Poteshkina N.G.1,2, Kovalevskaya E.A.2, Selivanova G.B.1
-
Affiliations:
- Pirogov Russian National Research Medical University
- City Clinical Hospital №52
- Issue: Vol 22, No 10 (2020)
- Pages: 34-38
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95305
- DOI: https://doi.org/10.26442/20751753.2020.10.200287
- ID: 95305
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Natalia S. Krylova
Pirogov Russian National Research Medical University; City Clinical Hospital №52
Email: krylova_n@list.ru
канд. мед. наук, доц. каф. общей терапии Москва, Россия
Maria Yu. Maslova
Pirogov Russian National Research Medical Universityассистент каф. общей терапии Москва, Россия
Natalia G. Poteshkina
Pirogov Russian National Research Medical University; City Clinical Hospital №52д-р мед. наук, проф., зав. каф. общей терапии Москва, Россия
Elena A. Kovalevskaya
City Clinical Hospital №52канд. мед. наук, зав. кардиологическим отд-нием Москва, Россия
Galina B. Selivanova
Pirogov Russian National Research Medical Universityд-р мед. наук, проф. каф. общей терапии Москва, Россия
References
- Elliott PM, Anastasakis A, Borger MA et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35 (39): 2733-79. doi: 10.1093/eurheartj/ehu284
- Gersh BJ, Maron BJ, Bonow RO et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/Ameri-can Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011; 142: e153-e203.
- Semsarian C, Ingles J, Maron MS, Maron BJ. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2015; 65 (12): 1249-54. doi: 10.1016/j.jacc.2015.01.019
- Maron BJ, Bonow RO, Cannon RO et al. Hypertrophic Cardiomyopathy. New Engl J Med 1987; 316 (14): 844-52. doi: 10.1056/nejm198704023161405
- Olivotto I, Maron MS, Adabag AS. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46 (3): 480-7.
- Canepa M, Pozios I, Vianello PF et al. Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly. Heart 2016; 102 (14): 1087-94. doi: 10.1136/heartjnl-2015-308764
- Hata Y, Ichimata S, Yamaguchi Y et al. Clinicopathological and Genetic Profiles of Cases with Myocytes Disarray - Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy. J Clin Med 2019; 8 (4): 463. doi: 10.3390/jcm8040463
- Mademont-Soler I, Mates J, Yotti R et al. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy. PLoS One 2017; 12 (8): e0181465.
- Kubo T, Kitaoka H, Okawa M et al. Hypertrophic cardiomyopathy in the elderly. Geriatr Gerontol Int 2010; 10 (1): 9-16.
- Niimura, H. Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly. Circulation 2002; 105 (4): 446-51. doi: 10.1161/hc0402.102990
- Razmara E, Garshasbi M. Whole-exome sequencing identifies R1279X of MYH6 gene to be associated with congenital heart disease. BMC Cardiovasc Dis 2018; 18 (1): 137. doi: 10.1186/s12872-018-0867-4
- Rowin EJ, Maron MS, Wells S et al. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy. J Am Heart Assoc 2019; 8 (21): e012041. doi: 10.1161/JAHA.119.012041
- Gupta T, Harikrishnan P, Kolte D et al. Outcomes of Acute Myocardial Infarction in Patients with Hypertrophic Cardiomyopathy. Am J Med 2015; 128 (8), 879-87.e1. doi: 10.1016/j.amjmed.2015.02.025
- Полякова А.А., Баранова Е.И., Семернин Е.Н. и др. Гендерные различия клинического течения и ремоделирования сердца при идиопатической гипертрофической кардиомиопатии в пожилом возрасте. Рос. кардиологический журн. 2018; 2: 13-8. doi: 10.15829/1560-4071-2018-2-13-18
- Van Velzen HG, Schinkel AFL, Baart SJ et al. Effect of Gender and Genetic Mutations on Outcomes in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol 2018; 122 (11): 1947-54. doi: 10.1016/j.amjcard.2018.08.040
- Kato TS. Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography. Circulation 2004; 110 (25): 3808-14. doi: 10.1161/01.cir.0000150334.69355.00
- Karam R, Lever HM, Healy BP. Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol 1989; 13 (3): 580-4. doi: 10.1016/0735-1097 (89)90596-2
- Aslam F, Haque A, Foody J, Shirani J. The Frequency and Functional Impact of Overlapping Hypertension on Hypertrophic Cardiomyopathy: A Single-Center Experience. J Clin Hypertens 2010; 12 (4): 240-5. doi: 10.1111/j.1751-7176.2009.00251.x2010
- Takeda A, Takeda N. Different pathophysiolody of cardiac hyperthrophy in hypertension and hypertrophic cardiomyopathy. J Mol Cell Cardiol 1997; 29 (11): 2961-5.
- Ковалевская Е.А., Крылова Н.С., Потешкина Н.Г. и др. Гипертрофическая кардиомиопатия в сочетании с ишемической болезнью сердца: 6-летняя история наблюдения. Рос. кардиологический журн. 2018; 9: 48-53. doi: 10.15829/1560-4071-2018-9-48-53
- Shin DG, Son J-W, Park JY et al. Impact of coronary artery anatomy on clinical course and prognosis in apical hypertrophic cardiomyopathy: analysis of coronary angiography and computed tomography. Korean Circ J 2015; 45 (1): 38-43. doi: 10.4070/kcj.2015.45.1.38
- Sorajja P, Ommen SR, Nishimura RA et al. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 2003; 108 (19): 2342-8. doi: 10.1161/01.CIR.0000097110.55312.BF
- Sado DM, Iqbal J. Hypertrophic cardiomyopathy in older patients. Clin Med (Lond) 2010; 10 (2): 196-8. doi: 10.7861/clinmedicine.10-2-196
- Каплунова В.Ю., Шакарьянц Г.А., Кожевникова М.В. и др. Гипертрофическая кардиомиопатия: формы и варианты течения, подходы к фармакотерапии. Клин. мед. 2017; 95 (12): 1061-9. doi: 10.18821/0023-2149-2017-95-12-1061-1069
- Полякова А.А., Гудкова А.Я., Крутиков А.Н. и др. Гипертрофическая кардиомиопатия в старшей возрастной группе: влияние факторов кардиометаболического риска и полиморфизма гена MADD. Артериальная гипертензия. 2018; 24 (1): 29-40. doi: 10.18705/1607-419X-2018-24-1-29-40
- Maron BJ, Rowin EJ, Casey SA et al. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >60 years of age. Circulation 2013; 127 (5): 585-93.
- Maron BJ, Casey SA, Haas TS et al. Hypertrophic Cardiomyopathy With Longevity to 90 Years or Older. Am J Cardiol 2012; 109 (9): 1341-7. doi: 10.1016/j.amjcard.2011.12.027
- Tsuda T, Hayashi K, Fujino N et al. Impact of Hypertrophic Cardiomyopathy on Prediction of Thromboembolism in Patients with Non-valvular Atrial Fibrillation. Heart Rhythm 2018. doi: 10.1016/j.hrthm.2018.11.029
- Haruki S, Minami Y, Hagiwara N. Stroke and Embolic Events in Hypertrophic Cardiomyopathy. Stroke 2016; 47 (4): 936-42. doi: 10.1161/strokeaha.115.012130
- Kubo T, Kitaoka H, Okawa M et al. Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy: results from Kochi RYOMA Study. Circ J 2009; 73: 1599-605.
- Siontis KC, Geske JB, Ong K et al. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc 2014; 3 (3): e001002. doi: 10.1161/JAHA.114.001002
- Javidgonbadi D, Andersson B, Abdon NJ et al. Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy. Open Heart 2019; 6 (1): e000963. doi: 10.1136/openhrt-2018-000963